Healthcare provider profile · identity verified

Uyioghosa E. Brown, MD

Family Practice · HARBOR CITY, CA · NPI 1760642425

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	424	155
Amlodipine Besylate	Amlodipine Besylate	315	115
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	247	47
Losartan Potassium	Losartan Potassium	210	71
Lisinopril	Lisinopril	187	68
Gabapentin	Gabapentin	165	53
Rosuvastatin Calcium	Rosuvastatin Calcium	147	56
Potassium Chloride	Potassium Chloride	140	55
Albuterol Sulfate Hfa	Albuterol Sulfate	139	54
Atenolol	Atenolol	137	51
Hydrochlorothiazide	Hydrochlorothiazide	125	49
Omeprazole	Omeprazole	123	46
Levothyroxine Sodium	Levothyroxine Sodium	114	35
Hydralazine Hcl	Hydralazine Hcl	98	37
Furosemide	Furosemide	87	38
Meloxicam	Meloxicam	85	27
Glipizide	Glipizide	84	31
Tramadol Hcl	Tramadol Hcl	81	24
Prednisone	Prednisone	78	55
Metformin Hcl	Metformin Hcl	72	27
Trazodone Hcl	Trazodone Hcl	71	29
Jardiance	Empagliflozin	66	21
Metoprolol Tartrate	Metoprolol Tartrate	63	23
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	61	22
Simvastatin	Simvastatin	60	20
Carvedilol	Carvedilol	59	18
Clonidine Hcl	Clonidine Hcl	58	17
Acetaminophen-Codeine	Acetaminophen With Codeine	57	15
Ozempic	Semaglutide	56	14
Triamcinolone Acetonide	Triamcinolone Acetonide	55	31
Lorazepam	Lorazepam	52	11
Metformin Hcl Er	Metformin Hcl	50	18
Pradaxa	Dabigatran Etexilate Mesylate	48	16
Allopurinol	Allopurinol	44	18
Clopidogrel	Clopidogrel Bisulfate	43	16
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	43	16
Morphine Sulfate Er	Morphine Sulfate	42	suppressed
Alendronate Sodium	Alendronate Sodium	41	16
Lovastatin	Lovastatin	41	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	37	15
Doxycycline Monohydrate	Doxycycline Monohydrate	36	29
Ezetimibe	Ezetimibe	36	13
Quetiapine Fumarate	Quetiapine Fumarate	35	11
Bisoprolol Fumarate	Bisoprolol Fumarate	34	13
Buspirone Hcl	Buspirone Hcl	34	suppressed
Lactulose	Lactulose	34	18
Ibuprofen	Ibuprofen	33	16
Trospium Chloride	Trospium Chloride	33	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	32	13
Eliquis	Apixaban	29	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	29	12
Tamsulosin Hcl	Tamsulosin Hcl	29	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	28	suppressed
Hydrocortisone	Hydrocortisone	27	11
Memantine Hcl	Memantine Hcl	27	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	27	suppressed
Spironolactone	Spironolactone	27	14
Terazosin Hcl	Terazosin Hcl	26	suppressed
Mupirocin	Mupirocin	25	14
Topiramate	Topiramate	25	suppressed
Acyclovir	Acyclovir	24	suppressed
Colchicine	Colchicine	24	suppressed
Duloxetine Hcl	Duloxetine Hcl	23	suppressed
Fluticasone Propionate	Fluticasone Propionate	23	suppressed
Pravastatin Sodium	Pravastatin Sodium	23	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	22	suppressed
Montelukast Sodium	Montelukast Sodium	22	suppressed
Clobetasol Propionate	Clobetasol Propionate	21	12
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	20	20
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	20	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	20	suppressed
Famotidine	Famotidine	19	suppressed
Lidocaine Hcl Viscous	Lidocaine Hcl	19	suppressed
Ondansetron Odt	Ondansetron	19	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	18	suppressed
Clonazepam	Clonazepam	17	suppressed
Humulin N	Insulin Nph Human Isophane	17	suppressed
Naproxen	Naproxen	17	12
Nortriptyline Hcl	Nortriptyline Hcl	17	suppressed
Verapamil Er	Verapamil Hcl	17	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	14
Sucralfate	Sucralfate	15	suppressed
Alvesco	Ciclesonide	14	suppressed
Methimazole	Methimazole	14	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	13	suppressed
Naloxone Hcl	Naloxone Hcl	13	suppressed
Sertraline Hcl	Sertraline Hcl	13	suppressed
Temazepam	Temazepam	13	suppressed
Clonidine	Clonidine	12	suppressed
Fluocinolone Acetonide	Fluocinolone/Shower Cap	12	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Scopolamine	Scopolamine	12	suppressed
Victoza 2-Pak	Liraglutide	12	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Estradiol	Estradiol	11	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error